We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




EndoStapling System Helps Treat Abdominal Aortic Aneurysms

By HospiMedica International staff writers
Posted on 14 Jun 2011
An innovative helical staple technology enables independent endograft fixation in endovascular aneurysm repair (EVAR) procedures, mimicking the hand suturing performed during open surgical repair of abdominal aortic aneurysm (AAA).

The Aptus EndoStapling System for EVAR procedures provides physicians with a technology to repair endovascular grafts that have exhibited migration or endoleaks (or are at risk of these complications), and is designed for use in sites in which augmented radial fixation and/or sealing is required to regain or maintain effective aortic aneurysm exclusion. More...
The system also can be used during de novo EVAR procedures in challenging proximal necks to enhance the endograft's inherent fixation and sealing mechanisms, potentially reducing distal migration.

The Aptus EndoStapling system is approved for use with Aptus' own endograft and with the Cook Medical Zenith endoraft, the Gore Excluder, and the Medtronic AneuRx, Endurant, and Talent endografts, in both initial implant and secondary repair settings. In an initial phase I trial with 21 patients, no device migration and no Type I, III, or IV endoleaks were detected one year after implantation; a larger follow-up trial with 155 patients is currently underway. The Aptus EndoStapling System is a product of Aptus Endosystems (Sunnyvale, CA, USA), and has received the European Community (CE) mark of approval.

"Given the recent publication of several long term EVAR outcome studies, we now recognize that late EVAR failure and the need for secondary intervention is a major underserved clinical need affecting many patients, and continued improvement in technology is required," said Jeff Elkins, CEO of Aptus Endosystems. "To date, physicians have had limited prophylactic and treatment options for graft migration and Type I endoleaks. The novel concept of independent and physician controlled proximal fixation using the EndoStapling System is a considerable step toward addressing long term complications and making EVAR a more definitive solution for treating aortic aneurysms."

"The use of the Aptus EndoStapling system will be a great advantage to simplify revision surgery for migrated endografts," said Jean Paul de Vries, MD, PhD, head of the department of Vascular Surgery at St. Antonius Hospital (Nieuwegein, The Netherlands). "The ability to staple migrated endografts to the aortic wall and to fixate extension cuffs will overcome most migrations and type IA endoleaks. This system truly mimics a sutured anastomosis."

Related Links:

Aptus Endosystems
St. Antonius Hospital



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.